READ: For awareness, Walgreens are limiting GLP-1s to one-month supply - Prime Therapeutics
READ: For awareness, Walgreens are limiting GLP-1s to one-month supply
Overview
Prime Therapeutics (Prime) was recently informed by Walgreens that they are limiting the availability of three-month supplies of glucagon-like peptide-1 (GLP-1) medications due to increased patient demand and industry-wide supply constraints. Walgreens assured that it will continue to dispense one-month supplies to ensure patients maintain uninterrupted access to the medication.
This change (effective as of Dec. 6, 2024) applies to all GLP-1 drug therapies and manufacturers. At this time, there is no exception for members to fill a three-month supply, however, Prime may request an exception for a three-month supply to be filled at Walgreen’s discretion in extenuating circumstances. As an alternative, members may also transfer their prescription to another in-network pharmacy to fill a three-month supply.
Next steps
There is no action needed by clients at this time. However, please note that Prime is monitoring the situation and maintaining regular communication with Walgreens to ensure member access and minimize any possible disruption. We will notify clients when Walgreens resumes filling three-month supplies of GLP-1s.
Please note, while Prime continues to look for opportunities to optimize client financials, this significant market change may shift financials or rebates per script performance and trigger an equitable adjustment to rebate guarantees based upon individual client contracts.
For questions, please contact your account team representative.